118 related articles for article (PubMed ID: 16095590)
1. Peptide YY (3 -36) inhibits dopamine and norepinephrine release in the hypothalamus.
Brunetti L; Orlando G; Ferrante C; Chiavaroli A; Vacca M
Eur J Pharmacol; 2005 Sep; 519(1-2):48-51. PubMed ID: 16095590
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus.
Brunetti L; Orlando G; Recinella L; Leone S; Ferrante C; Chiavaroli A; Lazzarin F; Vacca M
Peptides; 2008 Aug; 29(8):1377-81. PubMed ID: 18502539
[TBL] [Abstract][Full Text] [Related]
3. Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus.
Brunetti L; Orlando G; Recinella L; Michelotto B; Ferrante C; Vacca M
Eur J Pharmacol; 2004 Jun; 493(1-3):41-4. PubMed ID: 15189762
[TBL] [Abstract][Full Text] [Related]
4. Obestatin inhibits dopamine release in rat hypothalamus.
Brunetti L; Di Nisio C; Recinella L; Orlando G; Ferrante C; Chiavaroli A; Leone S; Di Michele P; Shohreh R; Vacca M
Eur J Pharmacol; 2010 Sep; 641(2-3):142-7. PubMed ID: 20553917
[TBL] [Abstract][Full Text] [Related]
5. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus.
Brunetti L; Recinella L; Orlando G; Michelotto B; Di Nisio C; Vacca M
Eur J Pharmacol; 2002 Nov; 454(2-3):189-92. PubMed ID: 12421646
[TBL] [Abstract][Full Text] [Related]
6. Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release.
Brunetti L; Orlando G; Michelotto B; Recinella L; Vacca M
Eur J Pharmacol; 2000 Dec; 409(2):103-7. PubMed ID: 11104823
[TBL] [Abstract][Full Text] [Related]
7. Orexigenic effects of omentin-1 related to decreased CART and CRH gene expression and increased norepinephrine synthesis and release in the hypothalamus.
Brunetti L; Orlando G; Ferrante C; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Shohreh R; Manippa F; Ricciuti A; Vacca M
Peptides; 2013 Jun; 44():66-74. PubMed ID: 23538212
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
[TBL] [Abstract][Full Text] [Related]
9. Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin neurotransmission.
Vécsei L; Kovács GL; Faludi M; Bollók I; Telegdy G
Acta Physiol Hung; 1985; 66(2):213-7. PubMed ID: 2864776
[TBL] [Abstract][Full Text] [Related]
10. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings.
Brunetti L; Michelotto B; Orlando G; Vacca M
Eur J Pharmacol; 1999 May; 372(3):237-40. PubMed ID: 10395017
[TBL] [Abstract][Full Text] [Related]
11. Peptide YY (PYY)3-36 modulates thyrotropin secretion in rats.
Oliveira KJ; Paula GS; Costa-e-Sousa RH; Souza LL; Moraes DC; Curty FH; Pazos-Moura CC
J Endocrinol; 2006 Nov; 191(2):459-63. PubMed ID: 17088415
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.
Abbott CR; Monteiro M; Small CJ; Sajedi A; Smith KL; Parkinson JR; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1044(1):127-31. PubMed ID: 15862798
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of noradrenaline on dopamine release from the hypothalamus of the rat].
Le Quan-Bui KH; Elghozi JL; Earnhardt JT; Meyer P; Devynck MA
J Pharmacol; 1982; 13(3):381-8. PubMed ID: 7132373
[TBL] [Abstract][Full Text] [Related]
14. Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake.
Serrano A; Pavón FJ; Tovar S; Casanueva F; Señarís R; Diéguez C; de Fonseca FR
Neuropharmacology; 2011 Mar; 60(4):593-601. PubMed ID: 21172362
[TBL] [Abstract][Full Text] [Related]
15. Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release.
Orlando G; Brunetti L; Di Nisio C; Michelotto B; Recinella L; Ciabattoni G; Vacca M
Eur J Pharmacol; 2001 Nov; 430(2-3):269-72. PubMed ID: 11711041
[TBL] [Abstract][Full Text] [Related]
16. Estradiol increases catecholamine levels in the hypothalamus of ovariectomized rats during the dark-phase.
Alfinito PD; Chen X; Mastroeni R; Pawlyk AC; Deecher DC
Eur J Pharmacol; 2009 Aug; 616(1-3):334-9. PubMed ID: 19576879
[TBL] [Abstract][Full Text] [Related]
17. A role of the histaminergic system for the control of feeding by orexigenic peptides.
Ishizuka T; Nomura S; Hosoda H; Kangawa K; Watanabe T; Yamatodani A
Physiol Behav; 2006 Oct; 89(3):295-300. PubMed ID: 16872646
[TBL] [Abstract][Full Text] [Related]
18. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus.
Date Y; Shimbara T; Koda S; Toshinai K; Ida T; Murakami N; Miyazato M; Kokame K; Ishizuka Y; Ishida Y; Kageyama H; Shioda S; Kangawa K; Nakazato M
Cell Metab; 2006 Oct; 4(4):323-31. PubMed ID: 17011505
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
[TBL] [Abstract][Full Text] [Related]
20. Tachykinins and the control of prolactin secretion.
Debeljuk L; Lasaga M
Peptides; 2006 Nov; 27(11):3007-19. PubMed ID: 16930771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
